|
0900 -
0915 |
Inauguration |
|
|
|
Plenary Session |
|
|
0915-1000
|
Experience with Kala Azar |
Hon'ble Dr. C. P. Thakur
Minister
for Small Scale Industries & Development of North Eastern
Region, |
|
1000-1045
|
An
overview on Research in India on
Leishmaniasis |
Prof.
N. K. Ganguly
DG, ICMR,
New Delhi |
|
1045-1115 |
Tea |
|
|
1115-1200 |
Keynote Address:
TDR and
its role in combating the global problems of Tropical
Diseases |
Dr.
Robert Ridley
WHO/TDR,
Geneva |
|
|
Session I |
|
|
1200-1230 |
Worldwide
increase of risk factors and clinical features of
Leishmaniasis outside the Indian subcontinent |
Dr. P.
Desjeux
WHO/TDR,
Geneva |
|
1230 -
1300 |
Clinical
features of Kala Azar |
Dr. S.
K. Bhattacharya
NICED,
Kolkatta |
|
1300 -
1315 |
Discussion
|
|
|
1315 -
1400 |
Lunch
|
|
Session II
|
|
|
Chairpersons |
|
|
1400 -
1430 |
Laboratory diagnosis of Kala Azar |
Dr.
Sarman Singh
AIIMS,
New Delhi |
|
1430 -
1500
|
Review of
recent advances in diagnostics |
Dr.
Marleen Boelaert
ITG |
|
1500 -
1530 |
Leishmania/HIV co-infections |
Dr. J.
Alvar
ISCII |
|
1530 -
1545 |
Discussion |
|
|
1545 -
1615 |
Tea |
|
Session III
|
|
|
Chairperson
|
|
|
1615 -
1645 |
Treatment of Kala Azar
|
Dr.
Shyam Sunder
BHU,
Varanasi |
|
1645 -
1715 |
Drug Resistance monitoring in
Leishmaniasis
|
Dr.Simon Croft
LSTM&H |
|
1715 -
1745 |
Experimental Models for use in Leishmanial vaccine
& Drug development research |
Dr.
Anuradha Dube
CDRI,
Lucknow |
|
1745-
1800 |
Discussion |
|
11 March 2004
|
Session IV
|
|
0815 -
0845 |
Breakfast |
|
|
|
Chairperson |
|
|
0900 -
0930 |
Immunology of Leishmaniasis with particular
reference to Kala Azar
|
Prof.
R. C. Mahajan
PGIMER,
Chandigarh |
|
0930 -
1000 |
Experiences with a Leishmanial
vaccine
|
Dr.
Madhubala
JNU, New
Delhi |
|
1000
-1030 |
Macrophage function in Leishmania donovani
infection |
Dr.
Syamal Roy
IICB,
Kolkata |
|
1030-
1100 |
Leishmanial vaccine - A global
overview
|
Dr.
Farrokh Modabbar
WHO, TDR |
|
1100 -
1115 |
Discussion |
|
|
1115 -
1145 |
Tea |
|
Session V
|
|
1145 -
1215 |
Organisation of a Leishmanial vaccine trial in
India
|
Dr. M.
D. Gupte
NIE,
Chennai |
|
1215 -
1245 |
Newer Drug targets
|
Dr.
Neelo Singh
CDRI,
Lucknow |
|
1245 -
1315 |
Drug
trials in Bihar - Experience of RMRI
|
Dr. P.
K. Sinha
RMRIMS,
Patna |
|
1315 -
1330 |
Discussion |
|
|
1330 –
1430 |
Lunch |
|
Session VI
|
|
|
Chairperson |
|
|
1430
-1500 |
Vector
bionomics
|
Dr.
Kamal Kishore
RMRIMS,
Patna |
|
1500 -
1530 |
Vector
Control - Recent advances
|
Dr. Jeevan
Bahadur Sherchand
ITDRC, Nepal |
|
1530 -
1600 |
Molecular
biology of Leishmania donovani with special
reference to development of therapeutics |
Dr. Hemanta Majumdar
IICB, Kolkata |
|
1600 -
1630 |
|
Dr.
Caryn Bern
CDC,
Atlanta |
|
1630-
1700 |
Tea |
|
|
1700 -
1730 |
Cutaneous leishmaniasis
in Sri Lanka
|
Dr.
Nadira Karunaweera
University of Colombo, Sri Lanka |
|
1730-1800 |
Leishmaniasis Case in Thailand
|
Dr.Yaowalark Sukthana
Faculty
of Tropical Medicine
Mahidol University, Bankok |
|
1800-1830 |
Valedictory session |
|